مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
Normal view MARC view ISBD view

Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. [electronic resource]

By:
  • Ghatalia, Pooja
Contributor(s):
  • Zibelman, Matthew
  • Geynisman, Daniel M
  • Plimack, Elizabeth R
Producer: 20170815Description: 7 p. digitalISSN:
  • 1534-6277
Subject(s):
  • Antibodies, Monoclonal -- pharmacology
  • Antineoplastic Agents -- pharmacology
  • B7-H1 Antigen -- antagonists & inhibitors
  • Biomarkers, Tumor
  • CTLA-4 Antigen -- antagonists & inhibitors
  • Carcinoma, Renal Cell -- drug therapy
  • Clinical Trials as Topic
  • Humans
  • Immunologic Factors -- pharmacology
  • Immunomodulation -- drug effects
  • Kidney Neoplasms -- drug therapy
  • Molecular Targeted Therapy
  • Patient Selection
  • Programmed Cell Death 1 Receptor -- antagonists & inhibitors
  • T-Lymphocytes -- drug effects
  • Treatment Outcome
Online resources:
  • Available from publisher's website
In: Current treatment options in oncology vol. 18
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 1 Evaluation of arrhythmia scoring systems and exercise-induced cardioprotection.
    by Miller, Lindsey E
  • 2 Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.
    by Quindry, John C
  • 3 The effect of resistance exercise on humoral markers of oxidative stress.
    by Hudson, Matthew B
  • 4 Beta-glucan, immune function, and upper respiratory tract infections in athletes.
    by Nieman, David C
Close

Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.

APA

Ghatalia P., Zibelman M., Geynisman D. M. & Plimack E. R. (20170815). Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. : Current treatment options in oncology.

Chicago

Ghatalia Pooja, Zibelman Matthew, Geynisman Daniel M and Plimack Elizabeth R. 20170815. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. : Current treatment options in oncology.

Harvard

Ghatalia P., Zibelman M., Geynisman D. M. and Plimack E. R. (20170815). Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. : Current treatment options in oncology.

MLA

Ghatalia Pooja, Zibelman Matthew, Geynisman Daniel M and Plimack Elizabeth R. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. : Current treatment options in oncology. 20170815.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site